Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice

被引:500
作者
Sonoshita, M
Takaku, K
Sasaki, N
Sugimoto, Y
Ushikubi, F
Narumiya, S
Oshima, M
Taketo, MM [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Tokyo, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Pharmacuet Sci, Dept Physiol Sci, Kyoto, Japan
[4] Asahikawa Med Coll, Dept Pharmacol, Asahikawa, Hokkaido 078, Japan
关键词
D O I
10.1038/nm0901-1048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arachidonic acid is metabolized to prostaglandin H-2 (PGH(2)) by cyclooxygenase (COX). COX-2, the inducible COX isozyme, has a key role in intestinal polyposis(1,2). Among the metabolites of PGH,, PGE, is implicated in tumorigenesis because its level is markedly elevated in tissues of intestinal adenoma and colon cancer(3). Here we show that homozygous deletion of the gene encoding a cell-surface receptor of PGE(2), EP2, causes decreases in number and size of intestinal polyps in Apc(Delta 716) mice (a mouse model for human familial adenomatous polyposis). This effect is similar to that of COX-2 gene disruption. We also show that COX-2 expression is boosted by PGE(2) through the EP2 receptor via a positive feedback loop. Homozygous gene knockout for other PGE(2) receptors, EP1 or EP3, did not affect intestinal polyp formation in Apc(Delta 716) mice. We conclude that EP2 is the major receptor mediating the PGE(2) signal generated by COX-2 upregulation in intestinal polyposis, and that increased cellular CAMP stimulates expression of more COX-2 and vascular endothelial growth factor in the polyp stroma.
引用
收藏
页码:1048 / 1051
页数:4
相关论文
共 26 条
[1]  
Cheng T, 1998, INVEST OPHTH VIS SCI, V39, P581
[2]  
COLEMAN RA, 1994, PHARMACOL REV, V46, P205
[3]  
Daniel TO, 1999, CANCER RES, V59, P4574
[5]   Aspirin, NSAIDs, and colon cancer prevention: Mechanisms? [J].
Gupta, RA ;
DuBois, RN .
GASTROENTEROLOGY, 1998, 114 (05) :1095-1098
[6]   Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast [J].
Hewitt, RE ;
Powe, DG ;
Morrell, K ;
Bailey, E ;
Leach, IH ;
Ellis, IO ;
Turner, DR .
BRITISH JOURNAL OF CANCER, 1997, 75 (02) :221-229
[7]   Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E2, and nonsteroidal anti-inflammatory drugs [J].
Hinz, B ;
Brune, K ;
Pahl, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) :790-796
[8]   New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF [J].
Holash, J ;
Wiegand, SJ ;
Yancopoulos, GD .
ONCOGENE, 1999, 18 (38) :5356-5362
[9]  
KARGMAN SL, 1995, CANCER RES, V55, P2556
[10]  
KUJUBU DA, 1991, J BIOL CHEM, V266, P12866